Cargando…
Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication‐Related Osteonecrosis of the Jaw in a Rat Model
Recently, several studies have demonstrated that intravenous administration of mesenchymal stem cells (MSCs) improve medication‐related osteonecrosis of the jaw (MRONJ), and paracrine effects of secretomes from MSCs have been hypothesized as the primary contributors. These secretomes in conditioned...
Autores principales: | Ogata, Kenichi, Matsumura, Mayu, Moriyama, Masafumi, Katagiri, Wataru, Hibi, Hideharu, Nakamura, Seiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124208/ https://www.ncbi.nlm.nih.gov/pubmed/30283893 http://dx.doi.org/10.1002/jbm4.10013 |
Ejemplares similares
-
Dental pulp-derived stem cell-conditioned media attenuates secondary Sjögren's syndrome via suppression of inflammatory cytokines in the submandibular glands
por: Ogata, Kenichi, et al.
Publicado: (2021) -
First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells
por: Katagiri, Wataru, et al.
Publicado: (2016) -
Iatrogenic risk of osteonecrosis of the jaw? Bone substitutes for dental implants: a warning from Japan
por: Hibi, Hideharu
Publicado: (2020) -
Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review
por: Furukawa, Sachiko, et al.
Publicado: (2017) -
Secreted factors from dental pulp stem cells improve Sjögren’s syndrome via regulatory T cell-mediated immunosuppression
por: Matsumura-Kawashima, Mayu, et al.
Publicado: (2021)